Live Breaking News & Updates on News Ratings For Kala Pharmaceuticals Daily

Stay updated with breaking news from News ratings for kala pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kala Pharmaceuticals (NASDAQ:KALA) Stock Price Down 4.5%

Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Free Report)’s share price was down 4.5% during mid-day trading on Thursday . The stock traded as low as $14.21 and last traded at $14.37. Approximately 68,731 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 693,209 shares. The stock had previously closed […] ....

Blackrock Inc , Millennium Management , Institutional Trading Of Kala Pharmaceuticals , Kala Pharmaceuticals , Virtu Financial , News Ratings For Kala Pharmaceuticals Daily , Kala Pharmaceuticals Inc , Renaissance Technologies , Columbus Asset Advisors , Kala Pharmaceuticals Stock Down , Free Report , Pharmaceuticals Stock Down , Kala Pharmaceuticals Daily , Nasdaq Kala ,

Kala Pharmaceuticals (NASDAQ:KALA) Trading Down 4.5%

Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Free Report) was down 4.5% during trading on Thursday . The stock traded as low as $14.21 and last traded at $14.37. Approximately 68,731 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 693,209 shares. The stock had previously closed at $15.04. Analysts […] ....

Mirabella Financial Services , Kala Pharmaceuticals Company Profile , Goldman Sachs Group Inc , Kala Pharmaceuticals Inc , Renaissance Technologies , Kala Pharmaceuticals , Hedge Funds Weigh In On Kala Pharmaceuticals , Columbus Asset Advisors , News Ratings For Kala Pharmaceuticals Daily , Kala Pharmaceuticals Trading Down , Free Report , Pharmaceuticals Trading Down , Financial Services , Sachs Group , Kala Pharmaceuticals Daily ,

Clear Street LLC Invests $1.88 Million in Kala Pharmaceuticals, Inc. (NASDAQ:KALA)

Clear Street LLC acquired a new position in shares of Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 49,390 shares of the company’s stock, valued at approximately $1,884,000. Kala Pharmaceuticals comprises about 0.0% of Clear Street […] ....

Justin Hanes , Roberts Langer , Kala Pharmaceuticals , Renaissance Technologies , Mirabella Financial Services , Wealth Concepts , Kala Pharmaceuticals Profile , Kala Pharmaceuticals Stock Down , Columbus Asset Advisors , Quarter For Kala Pharmaceuticals , Kala Pharmaceuticals Inc , Goldman Sachs Group Inc , News Ratings For Kala Pharmaceuticals Daily , Clear Street , Get Rating , Financial Services , Sachs Group , Integrated Wealth Concepts , Pharmaceuticals Stock Down , Kala Pharmaceuticals Daily , Nasdaq Kala , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Kala Pharmaceuticals (NASDAQ:KALA) Trading Up 3.1%

Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) shares shot up 3.1% during mid-day trading on Monday . The stock traded as high as $15.97 and last traded at $15.80. Approximately 78,700 shares traded hands during trading, a decline of 92% from the average daily volume of 937,802 shares. The stock had previously closed at $15.32. […] ....

Justin Hanes , Roberts Langer , Mirabella Financial Services , Kala Pharmaceuticals Price Performance , Kala Pharmaceuticals Inc , News Ratings For Kala Pharmaceuticals Daily , Renaissance Technologies , Vahanian Associates Financial Planning Inc , Kala Pharmaceuticals , Columbus Asset Advisors , Goldman Sachs Group Inc , Get Rating , Financial Services , Associates Financial Planning , Sachs Group , Kala Pharmaceuticals Daily , Nasdaq Kala ,

Kala Pharmaceuticals (NASDAQ:KALA) PT Raised to $22.00

Kala Pharmaceuticals (NASDAQ:KALA – Get Rating) had its price objective hoisted by investment analysts at HC Wainwright from $20.00 to $22.00 in a research note issued to investors on Wednesday, The Fly reports. HC Wainwright’s target price would suggest a potential upside of 28.58% from the company’s previous close. Kala Pharmaceuticals Stock Up 0.4 % […] ....

Roberts Langer , Justin Hanes , Mirabella Financial Services , Kala Pharmaceuticals Inc , Wealth Concepts , Hedge Funds Weigh In On Kala Pharmaceuticals , News Ratings For Kala Pharmaceuticals Daily , Kala Pharmaceuticals , Kala Pharmaceuticals Stock , Renaissance Technologies , Get Rating , Street Corp , Street Group , Kala Pharmaceuticals Daily , Nasdaq Kala , Boost Price Target , Hc Wainwright ,